The tumor was diagnosed as estrogen receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive invasive ductal carcinoma from core needle biopsy (Fig. 2a–c). The gene discussed is ESR1; the disease is invasive ductal breast carcinoma.